Received Oct 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 72742 | — |
PREGNANT; Drug Exposure During Pregnancy; Inappropriate age at vaccine administration; WRONG VACCINE; This non-serious prospective pregnancy case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 30-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 72742, expiry date 12-DEC-2026) for prophylaxis. Co-suspect products included RSV VACCINE PROT. SUBUNIT PREF 2V (ABRYSVO) for prophylaxis. On 01-OCT-2025, the patient received Arexvy. The patient did not receive ABRYSVO. On 01-OCT-2025, an unknown time after receiving Arexvy the patient experienced wrong vaccine administered (Verbatim: WRONG VACCINE), product use in unapproved population (Verbatim: Drug Exposure During Pregnancy) and inappropriate age at vaccine administration (Verbatim: Inappropriate age at vaccine administration). On an unknown date, the patient experienced vaccine exposure during pregnancy (Verbatim: PREGNANT). The outcome of the wrong vaccine administered, vaccine exposure during pregnancy, product use in unapproved population and inappropriate age at vaccine administration were not applicable. Pregnancy exposure: Pregnancy Exposure (Arexvy): Trimester unknown Pregnancy Exposure (ABRYSVO): Trimester unknown Estimated Delivery/Due date: 20-NOV-2025 Pregnancy Outcome: Pregnancy was ongoing Additional Information: GSK receipt date: 22-OCT-2025 The license practice nurse reported pregnant patient received Arexvy instead of Abrysvo. This case is 1 out of 6 cases reported by the same reporter.; Sender's Comments: US-GSK-US2025137791:SAME REPORTER US-GSK-US2025137785:SAME REPORTER US-GSK-US2025137784:SAME REPORTER